1.
J Pharm Pract
; 33(5): 705-707, 2020 Oct.
Artículo
en Inglés
| MEDLINE
| ID: mdl-31232145
RESUMEN
Although the interaction between methylene blue and serotonin reuptake inhibitors/serotonin norepinephrine reuptake inhibitors is well documented, there remains a paucity of literature on identifying patient groups who may be at risk for experiencing this interaction. Here, we report a case of methylene blue and venlafaxine-induced serotonin syndrome in a patient with cancer.